ClinicalTrials.Veeva

Menu

Influence of Alcohol Marketing Stimuli in Adults With Regular Alcohol Consumption (DEPREV_Phase_2)

R

Regional University Hospital Center (CHRU)

Status

Terminated

Conditions

Alcohol Abuse

Treatments

Other: questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT05125783
29BRC21.0178

Details and patient eligibility

About

Alcohol use is the second leading cause of preventable death after smoking. The Evin law was built in 1991 with the goal of reducing exposure to alcohol marketing among the youngest. But this law is currently extremely weakened, and in a press release of February 26, 2018, the French Society of Alcoology is alarmed by these developments.

Studies on the impact of alcohol marketing focus for the most part on young adolescents and the links between marketing exposure and alcohol initiation. But beyond these links, little work has been done on the impact of alcohol marketing on vulnerable subjects with regular alcohol consumption. Alcohol consumption is one of the very first causes of hospitalization in France. The damage is often limited to the notion of risks of dependence, but it can appear as soon as consumption of 1 standard unit/day and mainly concerns the 45-64 year olds. To investigator knowledge, there are no studies on the impact of alcohol marketing carried out among regular alcohol users with moderate or severe alcohol use disorders.

Enrollment

287 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient over 18 years of age
  • Patient with moderate to severe alcohol use disorders (beyond 3 out of 11 criteria on the DSM-5 scale)
  • Non-opposition of the patient

Exclusion criteria

  • Minor patient
  • Patient who has already participated in phase 1 of the project
  • Non-comprehension of the written French language
  • Refusal to participate in the study
  • Patient of legal age, deprived of liberty by a judicial or administrative decision or unable to express their consent

Trial contacts and locations

7

Loading...

Central trial contact

Morgane GUILLOU-LANDREAT, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems